Product Information
CITALOPRAM HBR 40 MG TABLET is a generic product labeled by Quallent Pharmaceuticals Health LLC, priced at $0.0423 per EA under NDC 82009010805. Its NADAC has been published 138 times since Nov 8, 2023.
Strength
40 mg/1
Manufacturer
Quallent Pharmaceuticals Health LLCNDC
82009010805
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CITALOPRAM HYDROBROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077031On Market Since
8/1/2023
Pharmacological Classes
Price Statistics
The NADAC for CITALOPRAM HBR 40 MG TABLET has been published 138 times since Nov 8, 2023, and over the history we have for it it has declined 6.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0423 per EA |
|---|---|
| All-time high | $0.0465 (Nov 13, 2024) |
| All-time low | $0.0355 (Nov 20, 2024) |
| 52-week high | $0.0464 |
| 52-week low | $0.0423 |
| Median price | $0.0447 |
| Average price | $0.0437 |
| Largest weekly change | -23.6% (Nov 20, 2024) |
| Weeks tracked | 138 |
| Tracking since | Nov 8, 2023 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CITALOPRAM HBR 40 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CITALOPRAM HBR 40 MG TABLET, manufactured by Quallent Pharmaceuticals Health LLC, is $0.0423 per EA (NDC 82009010805), effective Jun 24, 2026.
How has the price of CITALOPRAM HBR 40 MG TABLET changed over time?
Over the history we have for it, the NADAC for CITALOPRAM HBR 40 MG TABLET has declined 6.0%. It has been tracked across 138 weekly CMS publications since Nov 8, 2023.
What are the highest and lowest recorded NADAC prices for CITALOPRAM HBR 40 MG TABLET?
Since Nov 8, 2023, the NADAC for CITALOPRAM HBR 40 MG TABLET has ranged from a low of $0.0355 (Nov 20, 2024) to a high of $0.0465 (Nov 13, 2024), with a median of $0.0447 per EA.
Are there cheaper alternatives to CITALOPRAM HBR 40 MG TABLET?
2 NADAC-published products share the same active ingredient, strength, and dosage form as CITALOPRAM HBR 40 MG TABLET, but none are currently priced below it.
Who manufactures CITALOPRAM HBR 40 MG TABLET?
CITALOPRAM HBR 40 MG TABLET (NDC 82009010805) is labeled by Quallent Pharmaceuticals Health LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification